Cytotoxic evaluation of injectable cyclodextrin nanoparticles

Journal of Pharmacy and Pharmacology

Volumn 58, Issue 5, 2006, Pages 585-589

  Memisoglu Bilensoy, Erem ^a   Doǧan, A Lale ^a   Hincal, A Atilla ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ALIPHATIC COMPOUND; CYCLODEXTRIN DERIVATIVE; DRUG CARRIER; ESTER; NANOPARTICLE; NIMODIPINE; POLOXAMER; SURFACTANT; TETRAZOLIUM;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG RELEASE; ENCAPSULATION; FIBROBLAST CULTURE; HUMAN; HUMAN CELL; IN VITRO STUDY; MOUSE; NONHUMAN; PARTICLE SIZE; POLYMORPHONUCLEAR CELL; PRECIPITATION; ZETA POTENTIAL;

ANIMALS; BETA-CYCLODEXTRINS; CALCIUM CHANNEL BLOCKERS; CELL LINE; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG CARRIERS; DRUG EVALUATION, PRECLINICAL; HUMANS; MICE; NANOSTRUCTURES; NEUTROPHILS; NIMODIPINE; POLOXAMER; SOLUBILITY; SURFACE-ACTIVE AGENTS; TECHNOLOGY, PHARMACEUTICAL;

EID: 33646445455     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/jpp.58.5.0002     Document Type: Article

References (29)

1. Albers, E., Müller, B. W. (1995) Cyclodextrin derivatives in pharmaceuticals. CRC Crit. Rev. Ther. Drug Carrier Syst. 12(4): 311-337
2. Campling, B. G., Pym, J., Galbraith, P. R., Cole, S. P. C. (1988) Use of the MTT assay for rapid determination of chemosensitivity of human leukemic blast cells. Leuk. Res. 12(10): 823-831
3. Couvreur, P., Couarrazze, G., Devissaguet, J. P., Puisieux, F. (1996) Nanoparticles: preparation and characterization. In: Benita, S. (ed) Microencapsulation-methods and industrial applications. Marcel Dekker, New York, p 183-211
4. Couvreur, P., Barratt, G., Fattal, E., Legrand, P., Vauthier, C. (2002) Nanocapsule technology: a review. CRC Crit. Rev. Ther. Drug Carrier Syst. 19(2): 99-134
5. Duchene, D., Wouessidjewe, D., Ponchel, G. (1999) Cyclodextrins and carrier systems. J. Control. Release 62: 263-268
6. th International Symposium on Cyclodextrins, Editions de Santé, Paris, p 267-273
7. Fessi, H., Devissaguet, J. P., Thies, C. (1988) Process for the preparation of dispersible colloidal systems of a substance in the form of nanospheres. US Patent 5 118 529.
8. Frank, D. W., Gray, J. E., Weaver, R. N. (1976) Cyclodextrin nephrosis in the rat. Am. J. Pathol. 83: 367-382
9. Garcia, O., Quintela, P. A., Schuette, J. M., Vargas, R., Yoon, H. R., Kaifer, A. E. (1990) The interactions of vesicle-forming surfactants with cyclodextrins. In: Atwood, J. (ed) Inclusion phenomena and molecular recognition. Plenum Press, New York, p 251-259
10. Gelmers, H. J. (1985) Calcium-channel blockers in the treatment of migraine. Am. J. Cardiol. 55: 139B-143B.
11. Hansen, M. B., Nielsen, S. E., Berg, K. (1989) Re-examination and further develpoment of a precise and rapid dye method for measuring cell growth/cell kill. J. Immunol. Methods 119(2): 203-210
12. Hu, Y., Jiang, X., Ding, Y., Zhang, L., Yang, L., Yang, C., Zhang, J., Chen, J., Yang, Y. (2003) Preparation and drug release behaviors of nimodipine-loaded poly(caprolactone)-poly(ethylene oxide)-polylactide amphiphilic copolymer nanoparticles. Biomaterials 24: 2395-2404
13. Irie, T., Uekama, K. (1997) Pharmaceutical applications of cyclodextrins III. Toxicological issues and safety evaluation. J. Pharm. Sci. 86(2): 147-162
14. Langley, M. S., Sorkin, E. M. (1989) Nimodipine. A review of its phamacodynamic, pharmacokinetic and therapeutic properties. Drugs 37: 669-699
15. Lemos-Senna, E., Wouessidjewe, D., Lesieur, S., Duchene, D. (1998) Preparation of amphiphilic cyclodextrin nanospheres using the emulsion solvent evaporation method, influence of the surfactant on preparation and hydrophobic drug loading. Int. J. Pharm. 170: 119-128
16. Loftsson, T., Brewster, M. E. (1996) Pharmaceutical applications of cyclodextrins. I Drug solubilization and stabilization. J. Pharm. Sci. 85(10): 1017-1025
17. Memişoǧlu, E., Vural, I., Güç, D., Dogan, L., Hincal, A. A. (2002a) Evaluation of in vitro cytotoxicity of amphiphilic β-cyclodextrin nanospheres and nanocapsules on human fibroblasts and granulocytes. Eur. J. Pharm. Sci. 17 (suppl. 1): S117
18. Memijoglu, E., Bochot, A., Şen, M., Charon, D., Duchene, D., Hincal, A. A. (2002b) Amphiphilic β-cyclodextrins modified on the primary face: synthesis, characterization and evaluation of their potential as novel excipients in the preparation of nanocapsules. J. Pharm. Sci. 95(1): 1214-1224
19. Memijoglu, E., Bochot, A., Özalp, M., Şen, M., Duchene, D., Hincal, A. A. (2003a) Direct formation of nanospheres from amphiphilic β-cyclodextrin inclusion complexes. Pharm. Res. 20(1): 117-125
20. Memipglu, E., Bochot, A., Şen, M., Duchene, D., Hincal, A. (2003b) Non-surfactant nanospheres of progesterone inclusion complexes with amphiphilic β-cyclodextrins. Int. J. Pharm. 251: 143-153
21. Mwakibete, H., Cristantino, R., Bloor, D. M., Wyn-Jones, E., Holzwarth, J. F. (1995) Reliability of the experimental methods to determine equilibrium constants for surfactant/cyclodextrin inclusion complexes. Langmuir 11: 57-60
22. Skiba, M., Wouessidjewe, D., Fessi, H., Devissaguet, J. P., Duchene, D., Puisieux, F. (1992a) Preparation et utilisations des nouveaux systemes colloidaux dispersibles a base de cyclodextrines, sous forme de nanospheres. French Patent 92 07287
23. Skiba, M., Wouessidjewe, D., Fessi, H., Devissaguet, J. P., Duchene, D., Puisieux, F. (1992b) Preparation et utilisations des nouveaux systemes colloidaux dispersibles a base de cyclodextrines, sous forme de nanocapsules. French Patent 92 07285
24. Skiba, M., Duchene, D., Puisieux, F., Wouessidjewe, D. (1996) Development of a new colloidal drug carrier from chemically-modified cyclodextrin: nanospheres and influence of physicochemical and technological factors on particle size. Int. J. Pharm. 129: 113-121
25. Stella, V. J., Rao, V. M., Zannou, E. E., Zia, V. (1999) Mechanisms of drug release from cyclodextrin complexes. Adv. Drug Del. Rev. 36: 3-16
26. Szejtli, J. (1998) Introduction and general overview of cyclodextrin chemistry. Chem. Rev. 98: 1743-1753
27. Veiga, M. D., Ahsan, F. (2000) Influence of surfactants (present in the dissolution media) on the release behaviour of tolbutamide from its inclusion complex with β-cyclodextrin. Eur. J. Pharm. Sci. 9: 2991-2999
28. Wouessidjewe, D., Skiba, M., Leroy-Lechat, F., Lemos-Senna, E., Puisieux, F., Duchene, D., (1996) A new concept in drug delivery based on 'skirt-shaped cyclodextrin aggregates'. Present state and future prospects. STP Pharma Sci. 6(1): 21-26
29. Zhang, P., Parrot-Lopez, H. (1992) Self-organizing systems based on amphiphilic cyclodextrins diesters. J. Phys. Org. Chem. 518-528